A 48-week, Open-label, 2-arm, Parallel-group, Randomized Exploratory Study to Assess Liver Iron Concentration Measured by FerriScan® (R2) Magnetic Resonance Imaging in B-thalassemia Subjects Administered SPD602 (SSP-004184AQ) or Exjade® (Deferasirox) for Treatment of Chronic Transfusional Iron Overload

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01927913

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:09.798042+00:00

Published At

2021-06-02T00:00:00+00:00

Record Updated At

2021-06-02

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Transfusional Iron Overload", "Iron Overload", "Iron Chelation", "Beta-thalassemia", "Transfusional Hemosiderosis", "Iron Metabolism Disorders", "Metabolic Diseases"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-06-02"

protocolSection.identificationModule.nctId

"NCT01927913"

protocolSection.identificationModule.officialTitle

"A 48-week, Open-label, 2-arm, Parallel-group, Randomized Exploratory Study to Assess Liver Iron Concentration Measured by FerriScan\u00ae (R2) Magnetic Resonance Imaging in B-thalassemia Subjects Administered SPD602 (SSP-004184AQ) or Exjade\u00ae (Deferasirox) for Treatment of Chronic Transfusional Iron Overload"

protocolSection.statusModule.overallStatus

"WITHDRAWN"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Transfusional Iron Overload (protocolSection.conditionsModule.conditions)
• Iron Overload (protocolSection.conditionsModule.conditions)
• Iron Chelation (protocolSection.conditionsModule.conditions)
• Beta-thalassemia (protocolSection.conditionsModule.conditions)
• Transfusional Hemosiderosis (protocolSection.conditionsModule.conditions)
• Iron Metabolism Disorders (protocolSection.conditionsModule.conditions)
• Metabolic Diseases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.